Success of chemotherapy and a liver transplant in a pediatric patient with hepatic angiosarcoma: A case report

Kristy Pilbeam, Ben Eidenschink, Megan Sulciner, Mark Luquette, Joseph P Neglia, Srinath Chinnakotla

Research output: Contribution to journalArticle

Abstract

Hepatic angiosarcoma is an extremely rare diagnosis in children, with fewer than 50 pediatric cases reported in the literature worldwide. This aggressive vascular sarcoma carries a very dismal prognosis and is known to be resistant to radiation, chemotherapy, and other vascular-targeted agents. Complete surgical resection is felt to provide the best chance for long-term survival. In patients with tumors not amenable to resection, a liver transplant can be considered. However, very few such transplants have been reported, given that they remain controversial due to high cancer recurrence and mortality post-transplant. Herein, we report the unique case of a 2-year-old child with localized hepatic angiosarcoma not amendable to resection who successfully underwent a liver transplant and received chemotherapy with six cycles of doxorubicin, docetaxel, and ifosfamide.

Original languageEnglish (US)
Article numbere13410
JournalPediatric transplantation
Volume23
Issue number4
DOIs
StatePublished - Jun 1 2019

Fingerprint

Hemangiosarcoma
Pediatrics
Transplants
Drug Therapy
Liver
docetaxel
Blood Vessels
Ifosfamide
Sarcoma
Doxorubicin
Neoplasms
Radiation
Recurrence
Survival
Mortality

Keywords

  • angiosarcoma
  • hepatic angiosarcoma
  • liver transplantation

PubMed: MeSH publication types

  • Case Reports

Cite this

Success of chemotherapy and a liver transplant in a pediatric patient with hepatic angiosarcoma : A case report. / Pilbeam, Kristy; Eidenschink, Ben; Sulciner, Megan; Luquette, Mark; Neglia, Joseph P; Chinnakotla, Srinath.

In: Pediatric transplantation, Vol. 23, No. 4, e13410, 01.06.2019.

Research output: Contribution to journalArticle

@article{54863ee88d48441991b1506dfc9139bf,
title = "Success of chemotherapy and a liver transplant in a pediatric patient with hepatic angiosarcoma: A case report",
abstract = "Hepatic angiosarcoma is an extremely rare diagnosis in children, with fewer than 50 pediatric cases reported in the literature worldwide. This aggressive vascular sarcoma carries a very dismal prognosis and is known to be resistant to radiation, chemotherapy, and other vascular-targeted agents. Complete surgical resection is felt to provide the best chance for long-term survival. In patients with tumors not amenable to resection, a liver transplant can be considered. However, very few such transplants have been reported, given that they remain controversial due to high cancer recurrence and mortality post-transplant. Herein, we report the unique case of a 2-year-old child with localized hepatic angiosarcoma not amendable to resection who successfully underwent a liver transplant and received chemotherapy with six cycles of doxorubicin, docetaxel, and ifosfamide.",
keywords = "angiosarcoma, hepatic angiosarcoma, liver transplantation",
author = "Kristy Pilbeam and Ben Eidenschink and Megan Sulciner and Mark Luquette and Neglia, {Joseph P} and Srinath Chinnakotla",
year = "2019",
month = "6",
day = "1",
doi = "10.1111/petr.13410",
language = "English (US)",
volume = "23",
journal = "Pediatric Transplantation",
issn = "1397-3142",
publisher = "Wiley-Blackwell",
number = "4",

}

TY - JOUR

T1 - Success of chemotherapy and a liver transplant in a pediatric patient with hepatic angiosarcoma

T2 - A case report

AU - Pilbeam, Kristy

AU - Eidenschink, Ben

AU - Sulciner, Megan

AU - Luquette, Mark

AU - Neglia, Joseph P

AU - Chinnakotla, Srinath

PY - 2019/6/1

Y1 - 2019/6/1

N2 - Hepatic angiosarcoma is an extremely rare diagnosis in children, with fewer than 50 pediatric cases reported in the literature worldwide. This aggressive vascular sarcoma carries a very dismal prognosis and is known to be resistant to radiation, chemotherapy, and other vascular-targeted agents. Complete surgical resection is felt to provide the best chance for long-term survival. In patients with tumors not amenable to resection, a liver transplant can be considered. However, very few such transplants have been reported, given that they remain controversial due to high cancer recurrence and mortality post-transplant. Herein, we report the unique case of a 2-year-old child with localized hepatic angiosarcoma not amendable to resection who successfully underwent a liver transplant and received chemotherapy with six cycles of doxorubicin, docetaxel, and ifosfamide.

AB - Hepatic angiosarcoma is an extremely rare diagnosis in children, with fewer than 50 pediatric cases reported in the literature worldwide. This aggressive vascular sarcoma carries a very dismal prognosis and is known to be resistant to radiation, chemotherapy, and other vascular-targeted agents. Complete surgical resection is felt to provide the best chance for long-term survival. In patients with tumors not amenable to resection, a liver transplant can be considered. However, very few such transplants have been reported, given that they remain controversial due to high cancer recurrence and mortality post-transplant. Herein, we report the unique case of a 2-year-old child with localized hepatic angiosarcoma not amendable to resection who successfully underwent a liver transplant and received chemotherapy with six cycles of doxorubicin, docetaxel, and ifosfamide.

KW - angiosarcoma

KW - hepatic angiosarcoma

KW - liver transplantation

UR - http://www.scopus.com/inward/record.url?scp=85064718262&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85064718262&partnerID=8YFLogxK

U2 - 10.1111/petr.13410

DO - 10.1111/petr.13410

M3 - Article

C2 - 31012199

AN - SCOPUS:85064718262

VL - 23

JO - Pediatric Transplantation

JF - Pediatric Transplantation

SN - 1397-3142

IS - 4

M1 - e13410

ER -